Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Immunol. 2020 May 22;205(1):272–281. doi: 10.4049/jimmunol.2000054

Figure 7. T cell activation metrics are predictive for GVHD across graft sources.

Figure 7.

T cell activation markers that were significantly different between non-GVHD and GVHD NBSGW mice (Fig 4 & 5) were validated in BM, CB, MB and PB graft sources (A-C). (D-F) Receiver operator characteristic (ROC) analysis was performed on % blasting T cells (D), T cell burden in peripheral blood (E) and plasma IFNγ concentration (F) to test their efficacy as predictive biomarkers of GVHD.